|
|
|
| Research progress of Notch signaling pathway in prostate cancer |
| LU Sheng CHEN Jie TIAN Lang ZHAO Wei CHEN Zhiwei WANG Yan |
| Department of Urinary Surgery, Zunyi Medical University Third Affiliated Hospital the First People’s Hospital of Zunyi, Guizhou Province, Zunyi 563000, China |
|
|
|
Abstract Prostate cancer is one of the common malignant tumors in the genitourinary system, which seriously threatens the health of patients. There are various treatment methods for prostate cancer, but the effect of various treatments is not ideal, and eventually it will develop into castration-resistant prostate cancer. Notch signaling pathway is currently one of the latest hotspots in cancer research. Notch signaling pathway is closely related to the occurrence, progression, and metastasis of various malignant tumors. This article reviews the role of Notch signaling pathway in prostate cancer (angiogenesis, cancer cell proliferation, and metastasis).
|
|
|
|
|
|
[1] Suresh S，Irvine AE. The NOTCH signaling pathway in normal and malignant blood cell production [J]. J Cell Commun Signal，2015，9（1）：5-13.
[2] Falo-Sanjuan J，Bray SJ. Decoding the Notch signal [J]. Dev Growth Diffe，2020，62（1）：4-14.
[3] Gratton R，Tricarico PM，d’Adamo AP，et al. Notch Signaling Regulation in Autoinflammatory Diseases[J]. Int J Mol Sci，2020，21（22）：8847-8854.
[4] Wang W，Okajima T，Takeuchi H. Significant Roles of Notch O-Glycosylation in Cancer [J]. Molecules，2022，27（6）：1783- 1801.
[5] 李佳琦，林天海，孙晟，等.肥胖与前列腺癌关系的研究进展[J].国际泌尿系统杂志，2018，38（1）：16-20.
[6] Deng G，Ma L，Meng Q，et al. Notch signaling in the prostate：critical roles during development and in the hallmarks of prostate cancer biology [J]. J Cancer Res Clin Oncol，2016， 142（3）：531-547.
[7] Aldahl J，Yu EJ，He Y，et al. A pivotal role of androgen signaling in Notch-responsive cells in prostate development，maturation，and regeneration [J]. Differentiation，2019，10（7）：1-10.
[8] Carvalho FL，Simons BW，Eberhart CG，et al. Notch signaling in prostate cancer：a moving target [J]. Prostate，2014，74（9）：933-945.
[9] Lee DH，Olson AW，Wang J，et al. Androgen action in cell fate and communication during prostate development at single-cell resolution [J]. Development，2021，148（1）：53-59.
[10] Kamińska A，Pardyak L，Marek S，et al. Notch signaling regulates nuclear androgen receptor AR and membrane androgen receptor ZIP9 in mouse Sertoli cells [J]. Andrology，2020，8（2）：457-472.
[11] Wang L，Zi H，Luo Y，et al. Inhibition of Notch pathway enhances the anti-tumor effect of docetaxel in prostate cancer stem-like cells [J]. Stem Cell Res Ther，2020，11（1）：258-265.
[12] Trindade A，Duarte A. Notch Signaling Function in the Angiocrine Regulation of Tumor Development [J]. Cells，2020， 9（11）：2467-2484.
[13] Zhang X，Hong R，Bei L，et al. Selenium binding protein 1 inhibits tumor angiogenesis in colorectal cancers by blocking the Delta-like ligand 4/Notch1 signaling pathway [J]. Transl Oncol，2022，18：101365.
[14] Yuri P，Shigemura K，Kitagawa K，et al. Increased tumor- associated macrophages in the prostate cancer microenvironment predicted patients’ survival and responses to androgen deprivation therapies in Indonesian patients cohort [J]. Prostate Int，2020，8（2）：62-69.
[15] Misiorek JO，Przybyszewska-Podstawka A，Ka?覥afut J，et al. Context Matters：NOTCH Signatures and Pathway in Cancer Progression and Metastasis [J]. Cells，2021，10（1）：94-125.
[16] Rice MA，Hsu EC，Aslan M，et al. Loss of Notch1 Activity Inhibits Prostate Cancer Growth and Metastasis and Sensitizes Prostate Cancer Cells to Antiandrogen Therapies [J]. Mol Cancer Ther，2019，18（7）：1230-1242.
[17] Zhang YQ，Liang YK，Wu Y，et al. Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTEN [J]. Cell Death Dis，2021，12（6）：502-517.
[18] Wang J，Lv X，Guo X，et al. Feedback activation of STAT3 limits the response to PI3K/AKT/mTOR inhibitors in PTEN-deficient cancer cells [J]. Oncogenesis，2021，10（1）：8-19.
[19] Yan Y，Huang H. Interplay Among PI3K/AKT，PTEN/FOXO and AR Signaling in Prostate Cancer [J]. Adv Exp Med Biol，2019，12（1）：319-331.
[20] Yu Y，Zhang Y，Guan W，et al. Androgen receptor promotes the oncogenic function of overexpressed Jagged1 in prostate cancer by enhancing cyclin B1 expression via Akt phosphorylation [J]. Mol Cancer Res，2014，12（6）：830-842.
[21] Pastushenko I，Blanpain C. EMT Transition States during Tumor Progression and Metastasis [J]. Trends Cell Biol，2019，29（3）：212-226.
[22] Bakir B，Chiarella AM，Pitarresi JR，et al. EMT，MET，Plasticity，and Tumor Metastasis [J]. Trends Cell Biol，2020，30（10）：764-776.
[23] Kar R，Jha NK，Jha SK，et al. A“NOTCH”Deeper into the Epithelial-To-Mesenchymal Transition （EMT） Program in Breast Cancer [J]. Genes （Basel），2019，10（12）：961-974.
[24] Sethi S，Macoska J，Chen W，et al. Molecular signature of epithelial-mesenchymal transition（EMT）in human prostate cancer bone metastasis [J]. Am J Transl Res，2010，3（1）：90-99.
[25] Rajaram P，Rivera A，Muthima K，et al. Second-Generation Androgen Receptor Antagonists as Hormonal Therapeutics for Three Forms of Prostate Cancer [J]. Molecules，2020，25（10）：2448-2474.
[26] De Wit R，de Bono J，Sternberg CN，et al. Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer [J]. N Engl J Med，2019，381（26）：2506-2518.
[27] Du Z，Li L，Sun W，et al. Systematic Evaluation for the Influences of the SOX17/Notch Receptor Family Members on Reversing Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells [J]. Front Oncol，2021，11：607291. |
|
|
|
